BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27214688)

  • 1. Evaluation of Central and Peripheral Visual Field Concordance in Glaucoma.
    Odden JL; Mihailovic A; Boland MV; Friedman DS; West SK; Ramulu PY
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2797-804. PubMed ID: 27214688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Clues to Predict the Presence of Parafoveal Scotoma on Humphrey 10-2 Visual Field Using a Humphrey 24-2 Visual Field.
    Park HY; Hwang BE; Shin HY; Park CK
    Am J Ophthalmol; 2016 Jan; 161():150-9. PubMed ID: 26476213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes.
    Ekici E; Moghimi S; Hou H; Proudfoot J; Zangwill LM; Do JL; Oh WH; Kamalipour A; Liebmann JM; De Moraes CG; Girkin CA; El-Nimri N; Weinreb RN
    Am J Ophthalmol; 2021 Mar; 223():229-240. PubMed ID: 33129812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Central Visual Field Severity in Glaucoma.
    Chakravarti T; Moghimi S; Weinreb RN
    J Glaucoma; 2022 Jun; 31(6):430-437. PubMed ID: 35649258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and Rates of Visual Field Loss across Different Disease Stages in Primary Open-Angle Glaucoma.
    Yousefi S; Mahmoudi Nezhad GS; Pourahmad S; Vermeer KA; Lemij HG
    Ophthalmol Glaucoma; 2018; 1(1):52-60. PubMed ID: 32672633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parafoveal scotoma progression in glaucoma: humphrey 10-2 versus 24-2 visual field analysis.
    Park SC; Kung Y; Su D; Simonson JL; Furlanetto RL; Liebmann JM; Ritch R
    Ophthalmology; 2013 Aug; 120(8):1546-50. PubMed ID: 23697959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression pattern of initial parafoveal scotomas in glaucoma.
    Su D; Park SC; Simonson JL; Liebmann JM; Ritch R
    Ophthalmology; 2013 Mar; 120(3):520-527. PubMed ID: 23149129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of visual field tests in glaucoma patients with a central visual field defect.
    Shin HY; Park HL; Park CK
    Can J Ophthalmol; 2019 Aug; 54(4):489-494. PubMed ID: 31358149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central-most Visual Field Defects in Early Glaucoma.
    Chakravarti T; Moghimi S; De Moraes CG; Weinreb RN
    J Glaucoma; 2021 Mar; 30(3):e68-e75. PubMed ID: 33273288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis.
    Verma S; Nongpiur ME; Atalay E; Wei X; Husain R; Goh D; Perera SA; Aung T
    Ophthalmology; 2017 Jul; 124(7):1065-1071. PubMed ID: 28372858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hemifield sector analysis protocol in multifocal visual evoked potential objective perimetry for the diagnosis and early detection of glaucomatous field defects.
    Mousa MF; Cubbidge RP; Al-Mansouri F; Bener A
    Korean J Ophthalmol; 2014 Feb; 28(1):49-65. PubMed ID: 24511212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to measure visual field progression in glaucoma patients using variational bayes linear regression.
    Murata H; Araie M; Asaoka R
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8386-92. PubMed ID: 25414192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method to measure and predict rates of regional visual field decay in glaucoma.
    Caprioli J; Mock D; Bitrian E; Afifi AA; Yu F; Nouri-Mahdavi K; Coleman AL
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4765-73. PubMed ID: 21467178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients.
    Phu J; Kalloniatis M
    Ophthalmology; 2021 Oct; 128(10):1405-1416. PubMed ID: 33722636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the Amsler Grid Test in Evaluating Glaucomatous Central Visual Field Defects.
    Su D; Greenberg A; Simonson JL; Teng CC; Liebmann JM; Ritch R; Park SC
    Ophthalmology; 2016 Apr; 123(4):737-43. PubMed ID: 26783097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of Glaucoma Hemifield Test Results and Visual Field Features in Glaucoma.
    Wang M; Pasquale LR; Shen LQ; Boland MV; Wellik SR; De Moraes CG; Myers JS; Wang H; Baniasadi N; Li D; Silva RNE; Bex PJ; Elze T
    Ophthalmology; 2018 Mar; 125(3):352-360. PubMed ID: 29103791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing 10-2 and 24-2 Visual Fields for Detecting Progressive Central Visual Loss in Glaucoma Eyes with Early Central Abnormalities.
    Wu Z; Medeiros FA; Weinreb RN; Girkin CA; Zangwill LM
    Ophthalmol Glaucoma; 2019; 2(2):95-102. PubMed ID: 31742250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial scotomas in normal tension glaucoma].
    Mizoue S; Iwase A; Matsumoto S; Yoshikawa K
    Nippon Ganka Gakkai Zasshi; 2014 Oct; 118(10):826-30. PubMed ID: 25423867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the presence of parafoveal scotoma in glaucomatous eyes with optic disc hemorrhages.
    Dias DT; Almeida I; Sassaki AM; Juncal VR; Ushida M; Lopes FS; Alhadeff P; Ritch R; Prata TS
    Eye (Lond); 2018 Oct; 32(10):1669-1674. PubMed ID: 29973693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of various cluster criteria used for the detection of glaucomatous visual field abnormalities.
    Wu Z; Medeiros FA; Weinreb RN; Girkin CA; Zangwill LM
    Br J Ophthalmol; 2020 Jun; 104(6):822-826. PubMed ID: 31530565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.